Eg for Novartis

Novartis, the Swiss drug maker, claimed Monday that research and innovation stand discouraged, if not ruined, in India. The company carped after losing a long-drawn legal battle in the Supreme Court to protect the patent of Glivec, an anti-cancer block buster.

Read Full Story>>